821.03KUSD
1.46
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00484M6012
CUSIP
00484M106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.51
Book Value
-127.17
Dividend Share
-
Dividend Yield
-
Earnings Share
-203.57
Wall Street Target Price
10.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
117,633,000
Gross Profit TTM
82,430,000
EBITDA
8,402,000
Profit Margin
-214.95%
Return On Assets TTM
-5.77%
Return On Equity TTM
-23.68%
Revenue Per Share TTM
94.713
Qtly Revenue Growth YOY
20.70%
Diluted Eps TTM
-203.57
Qtly Earnings Growth YOY
587.30%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.007
Price Book MRQ
0.0527
Enterprise Value Revenue
1
Enterprise Value EBITDA
0
129.07
0.97%158.03
0.65%17.80
0.00%28.35
0.00%129.30
-4.05%25.61
-1.80%16.70
-0.92%10.09
-0.69%18.00
-0.28%15.03
-0.27%